u Establish State AR Prevention Programs (“Protect Programs”), groups of
healthcare facilities in communities around the country that work together to
better track outbreaks, improve prescribing, and prevent infections
u Detect and respond rapidly to reduce spread of multidrug-resistant
gonorrhea (GC) and better treatment of GC
u Identify critical new interventions against multidrug-resistant tuberculosis
(TB) and expand pre-migration TB screening beyond immigrants and refugees
u Support development of next generation rapid susceptibility tests for
drug-resistant pathogens
u Identify new ways to prevent human infections caused by resistant bacteria (such as Salmonella) from food animals
using the National Antimicrobial Resistance Monitoring System (NARMS)
Track Superbugs; Measure Impact
Accelerate outbreak detection and prevention innovation
u New Detect Network of AR Regional Labs to improve response to outbreaks of urgent, serious, or concerning threats;
know faster which antibiotics work; and use cutting edge methods to track and get ahead of spread
u New AR Isolate Bank to provide a complete collection of current resistant threats; help keep pace with mutations; and
provide information for FDA-approval of products and for companies/researchers’ new tests and antibiotics
u Measure impact of antibiotics on human microbiome to learn if a healthy microbiome protects people and to learn if
antibiotics given to infants and elderly lead to health problems or higher risk of drug-resistant infection
u Double number of CDC’s Emerging Infections Program (EIP) sites to expand tracking to urgent and serious threats;
track evolving AR threats better; and improve understanding of who is at risk
u Enhance global partnerships for prevention and detection to combat AR internationally
Track and Improve Prescribing
Improve antibiotic use and reduce antibiotic resistance
u Provide real-time data about antibiotic use and trends in healthcare in
specific facilities and across regions using the National Healthcare Safety Network
(NHSN); set the standard for how facilities, communities, states, and the nation
can improve antibiotic use and reduce resistance
u Improve antibiotic prescribing practices in healthcare (antibiotic
stewardship) by ensuring all hospitals have effective stewardship programs and
evaluating state-to-state variations in antibiotic use to improve prescribing outside of hospitals
u Provide real-time data about antibiotic use and trends for outpatient care to better understand prescribing practices
and set national goals for improving antibiotic use
u Measure the impact of antibiotic use on human and animal health and greatly scale up rapid detection of AR
infections commonly transmitted through food to humans by collaborating with FDA and USDA to expand the National
Antimicrobial Resistance Monitoring System (NARMS)
u Establish State AR Prevention Programs (“Protect Programs”), groups ofhealthcare facilities in communities around the country that work together tobetter track outbreaks, improve prescribing, and prevent infectionsu Detect and respond rapidly to reduce spread of multidrug-resistantgonorrhea (GC) and better treatment of GCu Identify critical new interventions against multidrug-resistant tuberculosis(TB) and expand pre-migration TB screening beyond immigrants and refugeesu Support development of next generation rapid susceptibility tests fordrug-resistant pathogensu Identify new ways to prevent human infections caused by resistant bacteria (such as Salmonella) from food animalsusing the National Antimicrobial Resistance Monitoring System (NARMS)Track Superbugs; Measure ImpactAccelerate outbreak detection and prevention innovationu New Detect Network of AR Regional Labs to improve response to outbreaks of urgent, serious, or concerning threats;know faster which antibiotics work; and use cutting edge methods to track and get ahead of spreadu New AR Isolate Bank to provide a complete collection of current resistant threats; help keep pace with mutations; andprovide information for FDA-approval of products and for companies/researchers’ new tests and antibioticsu Measure impact of antibiotics on human microbiome to learn if a healthy microbiome protects people and to learn ifantibiotics given to infants and elderly lead to health problems or higher risk of drug-resistant infection
u Double number of CDC’s Emerging Infections Program (EIP) sites to expand tracking to urgent and serious threats;
track evolving AR threats better; and improve understanding of who is at risk
u Enhance global partnerships for prevention and detection to combat AR internationally
Track and Improve Prescribing
Improve antibiotic use and reduce antibiotic resistance
u Provide real-time data about antibiotic use and trends in healthcare in
specific facilities and across regions using the National Healthcare Safety Network
(NHSN); set the standard for how facilities, communities, states, and the nation
can improve antibiotic use and reduce resistance
u Improve antibiotic prescribing practices in healthcare (antibiotic
stewardship) by ensuring all hospitals have effective stewardship programs and
evaluating state-to-state variations in antibiotic use to improve prescribing outside of hospitals
u Provide real-time data about antibiotic use and trends for outpatient care to better understand prescribing practices
and set national goals for improving antibiotic use
u Measure the impact of antibiotic use on human and animal health and greatly scale up rapid detection of AR
infections commonly transmitted through food to humans by collaborating with FDA and USDA to expand the National
Antimicrobial Resistance Monitoring System (NARMS)
การแปล กรุณารอสักครู่..